Tag: cerebral protection

Boston Scientific closes acquisition of Claret Medical

Boston Scientific has announced that it has recently closed its acquisition of Claret Medical, which developed and commercialised the Sentinel cerebral embolic protection system—the...

Boston Scientific to buy cerebral protection system company

Boston Scientific has signed an agreement to acquire Claret Medical, which developed and commercialised the Sentinel cerebral embolic protection system. The device is used...

Carotid disease is not a risk factor for stroke or death...

A new study, published in Circulation: Cardiovascular Interventions, shows that one fifth of patients undergoing transcatheter aortic valve implantation (TAVI) have evidence of carotid...

First patient enrolled in phase II of REFLECT study of TriGuard...

Keystone Heart announced the launch of phase II of the REFLECT trial, which is evaluating the next-generation TriGuard 3 cerebral protection device. According to a...

Claret Medical closes on series C financing of US$14.5m

Claret Medical has announced that it has closed on a series C financing of US$14.5m led by Lightstone Ventures, with participation from existing investors...

ProtEmbo cerebral protection system used for first time

The ProtEmbo cerebral protection system (Protembis) has been used, to complement a transcatheter aortic valve implantation (TAVI) procedure, for the first time in a...

Keystone Heart accelerate trials for third-generation of its TriGuard device

Keystone Heart has announced plans to initiate clinical trials for a new, advanced version of its TriGuard cerebral embolic protection device. A press release...

Embolic protection device company raises US$5million in series B financing for...

Innovative Cardiovascular Solutions has announced today completion of an oversubscribed Series B round of financing totalling US$5M. The company is currently developing the Emblok...

Sentinel becomes first cerebral protection device to receive FDA approval

Claret Medical has received regulatory clearance from the FDA for its Sentinel cerebral protection system, via de novo classification, meaning that the device can...

Meta-analysis indicates embolic protection does reduce stroke after TAVI

In a research letter published in the Journal of the American College of Cardiology, Gennaro Giustino (The Icahn School of Medicine, Mount Sinai Hospital,...